CSPAX
Price
$74.61
Change
+$0.16 (+0.21%)
Updated
Sep 16 closing price
Net Assets
81.91B
GLNBX
Price
$22.20
Change
+$0.01 (+0.05%)
Updated
Sep 16 closing price
Net Assets
72.87M
Interact to see
Advertisement

CSPAX vs GLNBX

Header iconCSPAX vs GLNBX Comparison
Open Charts CSPAX vs GLNBXBanner chart's image
American Funds SMALLCAP World 529A
Price$74.61
Change+$0.16 (+0.21%)
VolumeN/A
Net Assets81.91B
MFS Global New Discovery B
Price$22.20
Change+$0.01 (+0.05%)
VolumeN/A
Net Assets72.87M
CSPAX vs GLNBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CSPAX vs. GLNBX commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSPAX is a Hold and GLNBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSPAX has more cash in the bank: 81.9B vs. GLNBX (72.9M). CSPAX pays higher dividends than GLNBX: CSPAX (0.56) vs GLNBX (0.00). CSPAX was incepted earlier than GLNBX: CSPAX (24 years) vs GLNBX (14 years). GLNBX (2.56) is less costly to investors than CSPAX (1.06). GLNBX is a more actively managed with annual turnover of: 37.00 vs. CSPAX (32.00). CSPAX has a lower initial minimum investment than GLNBX: CSPAX (250) vs GLNBX (1000). CSPAX annual gain was more profitable for investors over the last year : 10.35 vs. GLNBX (7.30). CSPAX return over 5 years is better than : 16.59 vs. GLNBX (11.28).
CSPAXGLNBXCSPAX / GLNBX
Total Expense Ratio1.062.1050%
Annual Report Gross Expense Ratio1.062.5641%
Fund Existence24 years14 years-
Gain YTD12.62411.895106%
Front Load4%N/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets81.9B72.9M112,346%
Annual Yield % from dividends0.560.00-
Returns for 1 year10.357.30142%
Returns for 3 years37.6639.2796%
Returns for 5 years16.5911.28147%
Returns for 10 years61.0655.35110%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HIAHX14.96N/A
N/A
Hartford Healthcare HLS IA
CEMFX15.51N/A
N/A
Cullen Emerging Markets High Div I
MDOAX11.66N/A
N/A
Morgan Stanley Developing Opportunity A
GCLLX17.85N/A
N/A
Goldman Sachs Enhanced U.S. Equity C
BHSRX57.01N/A
N/A
BlackRock Health Sciences Opps R